Browsing: Investing
By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects…
The Nasdaq-100 is heading down lately after a decent 2023 rally that seemed to fade as the summer turned into…
By Sabela Ojea Boston Scientific said its clinical trial to treat coronary in-stent restenosis with its investigational device met its…
Key News Asia was a sea of red except for Mainland China and Hong Kong following US tech’s drawdown and…
By Ben Glickman Innovation Beverage Group now plans to sell 1.2 million units in its initial public offering, compared with…
The Federal Reserve appears virtually certain to keep rates on hold at their November 1 interest rate announcement. That’s according…
By Josh Beckerman Energy Recovery shares were down 17% Wednesday after the company said Chief Executive Bob Mao departed but…
Nvidia (NVDA) has been a market darling since the beginning of the decade. This is no secret to any level…
By Dean Seal Life Time Group Holdings hopes to boost revenue next year by driving more sales of its branded…
If you don’t like these 10% and 12% dividends, well, you’re not really an income investor. That’s right. As I…